Trials / Completed
CompletedNCT00949936
Safety and Performance Study of the CAdiscTM-L Lumbar Spinal Disc Replacement Device For CE Marking
Debilitating Low Back paIn: Multi-centre Safety and performanCe invEstigation Of CAdiscTM-L, Total Disc ReplacemeNt Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Ranier Technology Limited · Industry
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this European Union (EU) study to evaluate the safety and performance of the CAdiscTM-L Lumbar Spinal Disc Replacement Device in the surgical replacement of the lumbar intervertebral discs (L3 to S1) for patients requiring surgical intervention for total lumbar disc replacement for the treatment of debilitating, chronic low back pain.
Detailed description
Study Design: International, multicenter, open, clinical investigation with comparison to pre-operative Currently there are two surgical procedures for the treatment of chronic low back pain: Spinal fusion and Total Disc Replacement. CAdisc™-L(Compliant Artificial disc - Lumbar) is a Lumbar total disc replacement product that preserves motion and restores disc height and stability Surgical access is via a routine anterior approach with discectomy (removal of the diseased disc), which is performed prior to implantation of the CAdisc™-L. Instruments are then used to prepare the disc space and to controllably place the replacement disc at the target point. It is not intended for the surgery to differ in type, duration or risk to any other device of this nature.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CAdisc™-L (Total Disc Replacement) |
Timeline
- Start date
- 2009-10-01
- Completion
- 2010-06-01
- First posted
- 2009-07-31
- Last updated
- 2010-10-15
Locations
4 sites across 4 countries: Belgium, Germany, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT00949936. Inclusion in this directory is not an endorsement.